Wall Street Cuts Mosaic Company Again: UBS Slashes Target to $27

Core Viewpoint - Mosaic Company is facing significant challenges in its phosphate business due to rising input costs and supply disruptions, leading to a downgrade by UBS and other Wall Street firms, with a new price target set at $27 from $33 [2][5][8]. Financial Performance - The phosphate cash cost of conversion increased to $131 per tonne in Q3 2025, up from $101 in the previous year [2][8]. - Sulfur prices surged to approximately $500 per metric ton late in Q3 2025, contributing to an expected EBITDA headwind of around $250 million in Q1 2026 [2][8]. Market Reactions - UBS downgraded Mosaic's rating from Buy to Neutral, reflecting a structural squeeze on phosphate profitability and delayed margin expansion now anticipated in 2027 instead of 2026 [5][7]. - Other firms, including Bank of America, also downgraded Mosaic, with Bank of America lowering its price target to $30 from $33 [8]. Analyst Insights - Analysts note that elevated sulfur and ammonia input costs, worsened by Middle East supply disruptions, are compressing stripping margins and limiting Mosaic's ability to benefit from high prices [3][7]. - The overall analyst consensus indicates a mean price target of $31.69, with a mix of Hold and Buy ratings, suggesting a more cautious outlook from the market [10]. Cash Flow and Capital Expenditures - Mosaic reported negative free cash flow of -$135 million in Q3 2025, driven by increased working capital and high capital expenditures, with management guiding for approximately $1.5 billion in capital expenditures in 2026 [9].